BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Category: Business
Dakon Montgomery Joins Eyecare Services Partners as Chief Operating Officer
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Dakon H. Montgomery as Chief Operating Officer, effective today. Mr. Montgomery comes to ESP with 12 years of le…
Global Luxury Eyewear Market 2019-2023 | 6% CAGR Projection Over the Next Five Years | Technavio
LONDON–(BUSINESS WIRE)– #ConsumerDiscretionary–The global luxury eyewear market size is expected to post a CAGR of over 6% during the period 2019-2023 according to Technavio
Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards
SAN DIEGO–(BUSINESS WIRE)–Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards
Ocular Therapeutix Announces Strategic Update and Operational Restructuring
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announ…
NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, reports financial results for the three and nine months ended S…
Global Diagnostic and Monitoring Ophthalmic Devices and Equipment Market Report 2019-2020: Major Players are Carl Zeiss Meditec, Alcon, Bausch + Lomb, Haag-Streit and Topcon – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Diagnostic And Monitoring Ophthalmic Devices And Equipment Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global diagnostic and monitoring ophthalmic devices and equipment market…
Global Ophthalmic Viscoelastic Devices Market to Surpass US$ 1642.65 Million By 2027
SEATTLE–(BUSINESS WIRE)– #CornealTransplantationSurgery–According to Coherent Market Insights, the global ophthalmic viscoelastic devices market was valued at US$ 685.3 million in 2018, and is projected to exhibit a CAGR of 10.2% during the forecast…
Ocuphire Pharma Announces Results from Two Phase 2 Clinical Studies of Nyxol® Eye Drops
FARMINGTON HILLS, Mich.–(BUSINESS WIRE)–Ocuphire Pharma, Inc., a clinical-stage pharmaceutical company focused on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders, announced statistically sig…
Global Antiglaucoma Drugs Market Analysis 2015-2019 and Forecast 2020-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Antiglaucoma Drugs Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. Where is the largest and fastest growing market for the antiglaucoma drugs? How does the market relate to the overal…
Aerpio Reports Third Quarter 2019 Financial Results and Provides Business Update
CINCINNATI–(BUSINESS WIRE)–Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today reported financial results for the third…
Aldeyra Therapeutics Reports Third-Quarter 2019 Financial Results and Provides Updates on Anticipated Clinical Milestones
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, today re…
Alcon to Announce Third Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Announce Third Quarter 2019 Results
Alcon to Announce Third Quarter 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon to Announce Third Quarter 2019 Results
Glaukos Corporation Announces Third Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced finan…
Aerie Pharmaceuticals Reports Third Quarter 2019 Financial Results, Updates Full-Year 2019 Guidance and Provides Business Update
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Pharmacy Times Continuing Education™ Presents Live Virtual Symposium on Novel Therapies for Treating Neuromyelitis Optica Spectrum Disorder
CRANBURY, N.J.–(BUSINESS WIRE)– #NMOSD–Pharmacy Times Continuing Education™ Presents Live Virtual Symposium on Novel Therapies for Treating Neuromyelitis Optica Spectrum Disorder
Samsung Bioepis Enters into Commercialization Agreement for Next-Generation Biosimilar Candidates
INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. announced today that it has entered into a new commercialization agreement with Biogen (Nasdaq: BIIB) for two biosimilar candidates under development by Samsung Bioepis, SB11 (ranibizumab) and …
Vision Plan Customer Satisfaction Increases, J.D. Power Finds
COSTA MESA, Calif.–(BUSINESS WIRE)–Overall customer satisfaction among vision plan members has increased in 2019, driven by improved perceptions of value and coverage, J.D. Power finds.
STAAR Surgical to Host Investor and Analyst Day on November 8, 2019
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced today that the Company will host an Investor and Ana…